These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9173033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F, Hauw JJ.
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [Abstract] [Full Text] [Related]

  • 8. Alternative drug therapies for dementia.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703
    [Abstract] [Full Text] [Related]

  • 9. Advances in the treatment of Alzheimer's disease.
    Schneider LS.
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract] [Full Text] [Related]

  • 10. New drugs for Alzheimer's disease.
    Delagarza VW.
    Am Fam Physician; 1998 Oct 01; 58(5):1175-82. PubMed ID: 9787282
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's disease: clinical treatment options.
    Reichman WE.
    Am J Manag Care; 2000 Dec 01; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [Abstract] [Full Text] [Related]

  • 12. [Perspectives of therapy of Alzheimer's disease].
    Sienkiewicz-Jarosz H, Kostowski W.
    Psychiatr Pol; 2000 Dec 01; 34(4):623-40. PubMed ID: 11059261
    [Abstract] [Full Text] [Related]

  • 13. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R.
    MMW Fortschr Med; 2002 May 06; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [Abstract] [Full Text] [Related]

  • 14. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A.
    Neuropsychiatr; 2007 May 06; 21(3):230-3. PubMed ID: 17915184
    [Abstract] [Full Text] [Related]

  • 15. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE.
    J Nutr Health Aging; 2007 May 06; 11(4):327-9. PubMed ID: 17653492
    [Abstract] [Full Text] [Related]

  • 16. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L, Schmitt B, Calabrese P, Diener H, Förstl H, Gertz HJ, Hallauer JF, Hampel H, Ihl R, Rieke K, Riepe M, Supprian T.
    Dtsch Med Wochenschr; 2005 Feb 25; 130(8):408-12. PubMed ID: 15717252
    [No Abstract] [Full Text] [Related]

  • 17. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.
    Am J Geriatr Pharmacother; 2006 Feb 25; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [Abstract] [Full Text] [Related]

  • 18. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
    Franke AG, Lieb K, Fellgiebel A.
    Fortschr Neurol Psychiatr; 2009 Jun 25; 77(6):326-33. PubMed ID: 19504422
    [Abstract] [Full Text] [Related]

  • 19. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C, Holsboer F.
    Fortschr Neurol Psychiatr; 1998 Mar 25; 66(3):113-21. PubMed ID: 9565761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.